Sablich Kim
CIK 0001758790
EVP, GM of U.S., Commercial MaDirector
Filings
7
Latest Jun 7, 2023
Issuers covered
2
Showing
7 of 7
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 0% | -3.6% | -2.4% | -2.4% | -7.5% |
| 90 days | 8 | 88% | +3.3% | +2.4% | +7.8% | -1.1% |
| 180 days | 8 | 88% | +1.5% | +2.3% | +2.3% | -1.2% |
| 365 days | 8 | 100% | +16.4% | +16.9% | +16.9% | +13.6% |
Issuers
Companies where Sablich Kim has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 5 | Jun 7, 2023 |
| EIGR | Eiger Biopharmaceuticals, Inc. | 2 | Mar 3, 2023 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|